PMH11 A SWEDISH PHARMACOECONOMIC EVALUATION OF ESCITALOPRAM, A NEW SSRI- COMPARISON OF COST-EFFECTIVENESS BETWEEN ESCITALOPRAM, CITALOPRAM, FLUOXETINE AND VENLAFAXINE
Abstract
Authors
C Franois F Henriksson M Toumi A Kornfeld